Product Monograph situation
We would like to get your thoughts on a potential situation and how it could affect marketing communication tools.
Product A: no existing indication, completely new to the market. Product B: Has an NOC for indication X.
Scenario: Single-use of Product A combined with ongoing or longer use of Product B is granted NOC for indication Z (i.e. PM for Product A) ahead of Product B receiving an additional indication for Z (PM for product B). Note that both products are undergoing Health Canada review for indication Z with the exact same data/ studies. The timing, however, may not be simultaneous.
Questions: (1) Can the logos of Product A and B be used on promotional pieces? (2) Can we callout the dosing of Product B explicitly? (3) Can information on Product A and B have equal prominence within pieces? (4) Given that product B already has an indication, an HCP and patient website already exists, can we send HCP/patients to Product B’s website (in a specific location) to get information on indication Z? (5) What are key considerations with respect to promotion?
Yin Man last edited by Patrick Massad
Thank you for your question. There are many factors that will affect the direction and use of both product logos in APS. This forum is not intended to address the specific and complex scenario that has been described. We suggest a consult meeting be arranged with PAAB to fully disclose the nature of the promotion and the content in the respective product monographs. We are unable to provide guidance without further information. Consult meetings may be arranged through our administrative team at firstname.lastname@example.org